BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27930628)

  • 1. Should we consider adjuvant therapy for rectal cancer after neoadjuvant chemoradiotherapy?
    Benson AB
    Clin Adv Hematol Oncol; 2016 Oct; 14(10):778-781. PubMed ID: 27930628
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal wait between long-course neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: a dilemma.
    Aggarwal G; Roy MK; Banerjee S
    ANZ J Surg; 2014; 84(1-2):4-5. PubMed ID: 24616925
    [No Abstract]   [Full Text] [Related]  

  • 3. Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
    Healey Bird BRJ
    Br J Surg; 2020 Dec; 107(13):1705-1707. PubMed ID: 33104240
    [No Abstract]   [Full Text] [Related]  

  • 4. [Optimal timing of surgery for rectal cancer after neoadjuvant chemoradiotherapy: which patients would benefit from waiting?].
    Petersen C
    Strahlenther Onkol; 2013 Oct; 189(10):904-6. PubMed ID: 23963207
    [No Abstract]   [Full Text] [Related]  

  • 5. Practice parameters for the management of rectal cancer (revised).
    Monson JR; Weiser MR; Buie WD; Chang GJ; Rafferty JF; Buie WD; Rafferty J;
    Dis Colon Rectum; 2013 May; 56(5):535-50. PubMed ID: 23575392
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour response to neoadjuvant chemoradiation within lateral pelvic nodes: another step towards precision surgery.
    Perez RO; Daneri MD; Vailati B; São Julião GP
    Tech Coloproctol; 2018 May; 22(5):323-324. PubMed ID: 29749574
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer.
    Persiani R; Biondi A; Gambacorta MA; Bertucci Zoccali M; Vecchio FM; Tufo A; Coco C; Valentini V; Doglietto GB; D'Ugo D
    Br J Surg; 2014 Jan; 101(2):133-42. PubMed ID: 24375303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Della Vittoria Scarpati G; Falcetta F; Carlomagno C; Ubezio P; Marchini S; De Stefano A; Singh VK; D'Incalci M; De Placido S; Pepe S
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1113-9. PubMed ID: 22172905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in locally advanced rectal cancer with highly selective preoperative chemoradiotherapy.
    Williamson JS; Jones HG; Davies M; Evans MD; Hatcher O; Beynon J; Harris DA;
    Br J Surg; 2014 Sep; 101(10):1290-8. PubMed ID: 24924947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
    Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
    J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed surgery for rectal cancer patients receiving neoadjuvant chemoradiotherapy: a promising method in its infancy.
    Peng JY; Di JZ; Wang Y
    Dig Surg; 2012; 29(4):281-6. PubMed ID: 22922886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Molinari C; Matteucci F; Caroli P; Passardi A
    Clin Colorectal Cancer; 2015 Dec; 14(4):227-38. PubMed ID: 26170142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.
    Hu JJ; Liang JW; Wang Z; Zhang XM; Zhou HT; Hou HR; Zhou ZX
    J Surg Res; 2014 Apr; 187(2):438-44. PubMed ID: 24252856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer.
    Lee HY; Jung JH; Cho HM; Kim SH; Lee KM; Kim HJ; Lee JH; Shim BY
    Cancer Res Treat; 2015 Oct; 47(4):804-12. PubMed ID: 25687871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy?
    Patel JA; Fleshman JW; Hunt SR; Safar B; Birnbaum EH; Lin AY; Mutch MG
    Dis Colon Rectum; 2012 Mar; 55(3):249-55. PubMed ID: 22469790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques.
    Banerjee R; Chakraborty S; Nygren I; Sinha R
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1225-31. PubMed ID: 23182394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA
    Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
    Sclafani F; Peckitt C; Cunningham D; Tait D; Giralt J; Glimelius B; Keränen SR; Bateman A; Hickish T; Tabernero J; Thomas J; Brown G; Oates J; Chau I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):303-12. PubMed ID: 26031368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete clinical response to neoadjuvant chemoradiotherapy for rectal cancer: an Australasian perspective.
    Behrenbruch C; Ryan J; Lynch C; Wynn G; Heriot A
    ANZ J Surg; 2015 Mar; 85(3):103-4. PubMed ID: 25732390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.